5'-O-phosphonomethyl-2',3'-dideoxynucleosides: synthesis and anti-HIV activity. 1990

L Jie, and A Van Aerschot, and J Balzarini, and G Janssen, and R Busson, and J Hoogmartens, and E De Clercq, and P Herdewijn
Laboratory of Pharmaceutical Chemistry, Rega Institute for Medical Research, Leuven, Belgium.

5'-O-Phosphonomethylation of different pyrimidine 2',3'-dideoxynucleosides was accomplished by reaction of the latter with diethyl [(p-toylsulfonyl)oxy]methanephosphonate (1) in the presence of sodium hydride. The base-phosphonomethylated (15-19) and sugar-phosphonomethylated (8-12) derivatives could be readily distinguished by 1H and 13C NMR and MS analysis. Protection of the uracil or thymine residue with a N3-benzoyl group failed to prevent base modification. However, O4-methyl-protected 2',3'-dideoxyuridine readily afforded the 5'-O-phosphonomethylated derivative 12, which was converted to both the 2',3'-didoxyuridine analogue 27 and the 2',3'-dideoxycytidine counterpart 29. The 5'-O-phosphonomethyl derivatives of 3'-deoxythymidine (23), 2',3'-dideoxyuridine, (27), 2',3'-dideoxycytidine (29), 3'-O-methylthymidine (26), and 3'-amino-3'-deoxythymidine (28) did not show an appreciable anti-HIV activity in MT-4 cells. In contrast, the 5'-O-phosphonomethyl derivatives of 3'-deoxy-3'-fluorothymidine (24) and 3'-azido-3'-deoxythymidine (25) inhibited HIV-1 cytopathogenicity by 50% at a concentration of approximately 1 microM.

UI MeSH Term Description Entries
D009943 Organophosphorus Compounds Organic compounds that contain phosphorus as an integral part of the molecule. Included under this heading is broad array of synthetic compounds that are used as PESTICIDES and DRUGS. Organophosphorus Compound,Organopyrophosphorus Compound,Organopyrophosphorus Compounds,Compound, Organophosphorus,Compound, Organopyrophosphorus,Compounds, Organophosphorus,Compounds, Organopyrophosphorus
D002621 Chemistry A basic science concerned with the composition, structure, and properties of matter; and the reactions that occur between substances and the associated energy exchange.
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000998 Antiviral Agents Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. Antiviral,Antiviral Agent,Antiviral Drug,Antivirals,Antiviral Drugs,Agent, Antiviral,Agents, Antiviral,Drug, Antiviral,Drugs, Antiviral
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D015224 Dideoxynucleosides Nucleosides that have two hydroxy groups removed from the sugar moiety. The majority of these compounds have broad-spectrum antiretroviral activity due to their action as antimetabolites. The nucleosides are phosphorylated intracellularly to their 5'-triphosphates and act as chain-terminating inhibitors of viral reverse transcription. 2',3'-Dideoxynucleosides,Dideoxyribonucleosides,ddNus,2',3' Dideoxynucleosides
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human
D055598 Chemical Phenomena The composition, structure, conformation, and properties of atoms and molecules, and their reaction and interaction processes. Chemical Concepts,Chemical Processes,Physical Chemistry Concepts,Physical Chemistry Processes,Physicochemical Concepts,Physicochemical Phenomena,Physicochemical Processes,Chemical Phenomenon,Chemical Process,Physical Chemistry Phenomena,Physical Chemistry Process,Physicochemical Phenomenon,Physicochemical Process,Chemical Concept,Chemistry Process, Physical,Chemistry Processes, Physical,Concept, Chemical,Concept, Physical Chemistry,Concept, Physicochemical,Concepts, Chemical,Concepts, Physical Chemistry,Concepts, Physicochemical,Phenomena, Chemical,Phenomena, Physical Chemistry,Phenomena, Physicochemical,Phenomenon, Chemical,Phenomenon, Physicochemical,Physical Chemistry Concept,Physicochemical Concept,Process, Chemical,Process, Physical Chemistry,Process, Physicochemical,Processes, Chemical,Processes, Physical Chemistry,Processes, Physicochemical
D018894 Reverse Transcriptase Inhibitors Inhibitors of reverse transcriptase (RNA-DIRECTED DNA POLYMERASE), an enzyme that synthesizes DNA on an RNA template. Reverse Transcriptase Inhibitor,Inhibitors, Reverse Transcriptase,Inhibitor, Reverse Transcriptase,Transcriptase Inhibitor, Reverse

Related Publications

L Jie, and A Van Aerschot, and J Balzarini, and G Janssen, and R Busson, and J Hoogmartens, and E De Clercq, and P Herdewijn
February 1992, Journal of medicinal chemistry,
L Jie, and A Van Aerschot, and J Balzarini, and G Janssen, and R Busson, and J Hoogmartens, and E De Clercq, and P Herdewijn
January 2003, Nucleosides, nucleotides & nucleic acids,
L Jie, and A Van Aerschot, and J Balzarini, and G Janssen, and R Busson, and J Hoogmartens, and E De Clercq, and P Herdewijn
July 1993, Archiv der Pharmazie,
L Jie, and A Van Aerschot, and J Balzarini, and G Janssen, and R Busson, and J Hoogmartens, and E De Clercq, and P Herdewijn
January 2004, Nucleosides, nucleotides & nucleic acids,
L Jie, and A Van Aerschot, and J Balzarini, and G Janssen, and R Busson, and J Hoogmartens, and E De Clercq, and P Herdewijn
October 1999, Nucleosides & nucleotides,
L Jie, and A Van Aerschot, and J Balzarini, and G Janssen, and R Busson, and J Hoogmartens, and E De Clercq, and P Herdewijn
January 1999, Nucleosides & nucleotides,
L Jie, and A Van Aerschot, and J Balzarini, and G Janssen, and R Busson, and J Hoogmartens, and E De Clercq, and P Herdewijn
April 2008, Chemical & pharmaceutical bulletin,
L Jie, and A Van Aerschot, and J Balzarini, and G Janssen, and R Busson, and J Hoogmartens, and E De Clercq, and P Herdewijn
November 1991, Acta chemica Scandinavica (Copenhagen, Denmark : 1989),
L Jie, and A Van Aerschot, and J Balzarini, and G Janssen, and R Busson, and J Hoogmartens, and E De Clercq, and P Herdewijn
January 1991, Advances in experimental medicine and biology,
L Jie, and A Van Aerschot, and J Balzarini, and G Janssen, and R Busson, and J Hoogmartens, and E De Clercq, and P Herdewijn
August 1991, Acta chemica Scandinavica (Copenhagen, Denmark : 1989),
Copied contents to your clipboard!